The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,576.00
Bid: 2,576.00
Ask: 2,580.00
Change: 6.00 (0.23%)
Spread: 4.00 (0.155%)
Open: 2,570.00
High: 2,594.00
Low: 2,562.00
Prev. Close: 2,576.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

14 Jan 2019 14:26

RNS Number : 0432N
Coca-Cola HBC AG
14 January 2019
 

Coca-Cola HBC AG

Conference call invitation for investors and analysts

2018 full-year results on Thursday, 14 February 2019

 

Zug, Switzerland - 14 January 2019 - Coca-Cola HBC AG (Coca‑Cola HBC) today announces that it will release its 2018 full-year results ended 31 December 2018 on Thursday, 14 February 2019 at 7:00 am London Time. The press release will be available as of that time on the company website: http://www.coca-colahellenic.com

 

Coca-Cola HBC's management will host a conference call for investors and analysts on Thursday, 14 February 2019 at 9:00 am London Time.

 

To join the call, participants should dial one of the following numbers and quote 'Coca‑Cola Hellenic' approximately 10 minutes ahead of the scheduled start time.

 

UK participants - toll free

0808 109 0700

US participants - toll free

1 866 966 5335

Greek participants - toll free

00800 1273 78

Swiss participants - toll free

0800 800 038

Standard international

+44 (0) 20 3003 2666

 

The conference call, which will include management's remarks followed by a question and answer session, will last approximately one hour.

 

Participants can log on to http://coca-colahellenic.com/en/investors/ for a live audio webcast of the conference call.

 

A recording of the call and its transcript will be made available on the Company website following the conference call at http://coca-colahellenic.com/en/investors/financial-results-and-presentations/

 

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +44 20 37 444 231

 basak.kotler@cchellenic.com

 

 

Joanna Kennedy

Investor Relations Manager

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

 

 

Vasso Aliferi

Investor Relations Manager

Tel: +41 44 835 9274

 vasso.aliferi@cchellenic.com

 

International media contact:

Teneo Blue Rubicon

Rob Morgan

Shona Buchanan

Tel: +44 20 7260 2700 robert.morgan@teneobluerubicon.com shona.buchanan@teneobluerubicon.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with an annual sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC has been listed in the Dow Jones Sustainability Indices since 2008, and ranked among the top beverage companies in the Global and European indices for the past four years. Coca-Cola HBC is also included in the FTSE4Good Index, rated "AAA" on the MSCI ESG index, rated "A" for Climate and Water by CDP and listed on the Sustainalytics and Vigeo rankings.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORSFLFLLFUSEEF
Date   Source Headline
15th Nov 20233:11 pmRNSPost 2023 AGM Shareholder Engagement
9th Nov 20233:20 pmRNSDirector/PDMR Shareholding
1st Nov 20234:30 pmRNSCCH Completes the acquisition of Finlandia Vodka
1st Nov 20231:31 pmRNSBlock listing Interim Review
31st Oct 20237:00 amRNSStrong growth driving further value creation
18th Oct 20233:42 pmRNSDirector/PDMR Shareholding
5th Oct 202310:21 amRNSNotice of Results
2nd Oct 20239:23 amRNSIssue of equity and total voting rights
21st Sep 202311:01 amRNSDirector/PDMR Shareholding
19th Sep 20231:02 pmRNSDirector/PDMR Shareholding
14th Sep 20232:04 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSDirector/PDMR Shareholding
1st Sep 202311:51 amRNSDirector/PDMR Shareholding
18th Aug 202312:16 pmRNSDirector/PDMR Shareholding
18th Jul 20231:06 pmRNSDirector/PDMR Shareholding
11th Jul 20233:53 pmRNSNotice of Results
7th Jul 20237:00 amRNSTRADING UPDATE
3rd Jul 20239:12 amRNSDirector/PDMR Shareholding
3rd Jul 20238:32 amRNSIssue of equity and total voting rights
23rd Jun 20234:04 pmRNSDirector/PDMR Shareholding
21st Jun 202311:05 amRNSDirector/PDMR Shareholding
21st Jun 202310:46 amRNSDirector/PDMR Shareholding
19th Jun 20233:06 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSCCH to acquire Finlandia Vodka from Brown-Forman
1st Jun 202310:07 amRNSIssue of equity and total voting rights
25th May 20237:00 amRNSCoca-Cola HBC Investor Day
18th May 20232:50 pmRNSDirector/PDMR Shareholding
18th May 20232:46 pmRNSDirector/PDMR Shareholding
17th May 20233:44 pmRNSCCH - Board Committees Composition
17th May 20233:37 pmRNSResult of AGM
4th May 20232:43 pmRNSAthens Exchange trading date of ordinary shares
3rd May 20237:00 amRNSStrategic progress driving strong revenue growth
2nd May 202311:23 amRNSBlock listing Interim Review
2nd May 202310:38 amRNSIssue of equity and total voting rights
24th Apr 20232:03 pmRNSNotice of Results-NEW TIME for the analysts call
18th Apr 20232:46 pmRNSDirector/PDMR Shareholding
13th Apr 20238:41 amRNSNotice of AGM
3rd Apr 20233:14 pmRNSNotice of Results
3rd Apr 20232:52 pmRNSIssue of equity and total voting rights
31st Mar 20232:54 pmRNSDirector/PDMR Shareholding
31st Mar 202312:30 pmRNSDirector/PDMR Shareholding
31st Mar 202312:22 pmRNSDirector/PDMR Shareholding
31st Mar 20239:11 amRNSDirector/PDMR Shareholding
31st Mar 20238:52 amRNSDirector/PDMR Shareholding
24th Mar 20231:48 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:10 pmRNSDirector/PDMR Shareholding
21st Mar 20239:48 amRNSDirector/PDMR Shareholding
21st Mar 20239:20 amRNSDirector/PDMR Shareholding
20th Mar 20234:11 pmRNSAnnual Financial Report
17th Mar 20232:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.